Investors today birched Cochlear shares by close to 40% after a radical earnings update – their worst fall in 30 ... Read More The post Health Check: Cochlear’s grim earnings update is hard for ...

Cochlear’s biggest woe in an earnings downgrade relates to developed markets – notably the US which accounts for more than ..

Shares fall 1.2pc on healthcare rout; Cochlear ends at 10-year low; Treasury Wine restructure; CBA says FX hedging increasing ...

Three of the top four ASX biotechs are facing a harsh reality check as investors question the ‘stronger for longer’ mentality ...

WA Gold Limited (ASX:WAU) has unveiled a robust economic profile for initial mining at its Abercromby gold project in WA with ...

Cochlear reaffirmed guidance for FY 2025 underlying net profit between $410 million and $430 million, though it expects to achieve the lower end of this range. The revision is driven by weaker ...

A leading analyst believes the historic selloff in Cochlear shares could present a unique buying opportunity. The post Down 43% this week, are Cochlear shares now the best bargain buy of the year?